ATNM (Actinium Corp) מכפיל P/E עתידי

The expected P/E ratio of Actinium Pharmaceuticals (ATNM) reflects the asset's value dynamics, where the 0.00 metric indicates the status of the current valuation. The business relies on the express delivery of short-lived isotopes. Strict control over the disposal of radioactive substances ensures compliance with environmental regulations. A network of local laboratories guarantees the efficiency of clinic supply, eliminating delays in drug transportation.
פילוחי נתונים אנליטיים מרוכזים עבור Actinium Pharmaceuticals (ATNM)

To identify fundamental stability drivers, it is essential to analyze the forward P/E, which compares the current market value of a share with the expected earnings per share. The price action of the forward P/E multiple for Actinium Pharmaceuticals (ATNM) reflects a revision of market expectations, which is directly linked to the successful completion of FDA regulatory milestones and the expansion of the patient base in blood cancer therapy.